Blog
New USPTO IDS Fees Raise Strategic Stakes for Biotech Filings
Key Takeaways- Effective Jan. 19, 2025, the USPTO implemented a new fee framework for IDS submissions, charging up to $800 for applications that list more than 200 references. The change is aimed at curbing over-disclosure and helping examiners focus on the most relevant prior art….
By: Polsinelli